ATRA vs DFS
Atara Biotherapeutics Inc (ATRA) versus DFS (DFS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
DFS (DFS) common stock.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
DFS does not have a complete income-statement cache yet.
ATRA currently screens at market cap $87.1M.
Not investment advice. Open the ATRA and DFS stock pages for the full models.
Not investment advice.